Early event-related potential changes during working memory activation predict rapid decline in mild cognitive impairment

被引:46
作者
Missonnier, P
Gold, G
Fazio-Costa, L
Michel, JP
Mulligan, R
Michon, AS
Ibáñez, V
Giannakopoulos, P
机构
[1] Univ Hosp Geneva, Dept Geriatr, CH-1226 Geneva, Switzerland
[2] Univ Hosp Geneva, Dept Psychiat, Geriatr Psychiat Serv, CH-1226 Geneva, Switzerland
[3] Univ Hosp Geneva, Neuroimaging Unit, CH-1226 Geneva, Switzerland
[4] Univ Lausanne Hosp, Serv Old Age Psychiat, Lausanne, Switzerland
来源
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 2005年 / 60卷 / 05期
关键词
D O I
10.1093/gerona/60.5.660
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background. The conversion of mild cognitive impairment (MCI) to Alzheimer's disease is associated with substantial compromise of neocortical circuits subserving rapid cognitive functions such as working memory. Event-related potential (ERP) analysis is a powerful tool to identify early impairment of these circuits, yet research for an electrophysiological marker of cognitive deterioration in MCI is scarce. Using a "2-back" activation paradigm, we recently described an electrophysiological correlate of working memory activation (positive-negative working memory [PNwm] component) over parietal electrodes. Methods. Ours was a longitudinal study of 24 MCI patients with ERP analysis at inclusion and neuropsychological follow-up after 1 year. We used ERP waveform subtraction analysis between the n-back and control tasks. Analysis of variance (ANOVA) was used to compare electroencephalograph latencies between progressive MCl (PMCl) and stable MCl (SMCl), and univariate regression was used to assess the relationship between neuropsychological measures at baseline and clinical outcome. Results. Thirteen (54%) MCl patients showed PMCl, and 11 (46%) remained stable (SMCl). In SMCl. a PNwm component with significantly larger density compared to baseline was identified when subtracting the detection task for both the 1- and 2-back tasks. In contrast, in PMCl, the PNwm component was absent in both 1-back and 2-back conditions. Neuropsychological variables and n-back test performance at inclusion did not predict cognitive deterioration 1 year later. Conclusions. In conjunction with recent functional imaging data, the present results support the notion of an early dysfunction of neural generators within the parietal cortex in MCl. They also reveal that the absence of the PNwm component may provide an easily applicable qualitative predictive marker of rapid cognitive deterioration in MCl.
引用
收藏
页码:660 / 666
页数:7
相关论文
共 50 条
[11]   Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study [J].
Drzezga, A ;
Lautenschlager, N ;
Siebner, H ;
Riemenschneider, M ;
Willoch, F ;
Minoshima, S ;
Schwaiger, M ;
Kurz, A .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (08) :1104-1113
[12]   Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease [J].
Encinas, M ;
de Juan, R ;
Marcos, A ;
Gil, P ;
Barabash, A ;
Fernaández, C ;
de Ugarte, C ;
Cabranes, JA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) :1473-1480
[13]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[14]   Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease [J].
Frodl, T ;
Hampel, H ;
Juckel, G ;
Bürger, K ;
Padberg, F ;
Engel, RR ;
Möller, HJ ;
Hegerl, U .
PSYCHOPHYSIOLOGY, 2002, 39 (02) :175-181
[15]  
GARDNER R JR, 1981, Journal of Clinical Neuropsychology, V3, P271, DOI 10.1080/01688638108403130
[17]   Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts [J].
Giannakopoulos, P ;
Hof, PR ;
Michel, JP ;
Guimon, J ;
Bouras, C .
BRAIN RESEARCH REVIEWS, 1997, 25 (02) :217-245
[18]   Clinical validity of aβ-protein deposition staging in brain aging and Alzheimer disease [J].
Gold, G ;
Kövari, E ;
Corte, G ;
Herrmann, FR ;
Canuto, A ;
Bussière, T ;
Hof, PR ;
Bouras, C ;
Giannakopoulos, P .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (10) :946-952
[19]   Clinical validity of Braak neuropathological staging in the oldest-old [J].
Gold, G ;
Bouras, C ;
Kövari, E ;
Canuto, A ;
Glaría, BG ;
Malky, A ;
Hof, PR ;
Michel, JP ;
Giannakopoulos, P .
ACTA NEUROPATHOLOGICA, 2000, 99 (05) :579-582
[20]  
GomezIsla T, 1996, J NEUROSCI, V16, P4491